文献速递甲状腺与浅表头颈US

影像组学联合ACR TI-RADS用于甲状腺结节:诊断性能、不必要穿刺率及列线图构建

Radiomics Combined with ACR TI-RADS for Thyroid Nodules: Diagnostic Performance, Unnecessary Biopsy Rate, and Nomogram Construction.
PubMed 文献 · Acad Radiol · 2024-10-04

回顾性纳入217个甲状腺结节,分为训练集152个和验证集65个,基于B型超声和应变弹性成像构建三种影像组学评分并联合高频超声特征建立列线图。列线图全队列AUC为0.909,高于ACR TI-RADS评分(P<0.001),不必要细针穿刺率显著低于ACR TI-RADS评分(P=0.007),决策曲线净临床获益优于ACR TI-RADS评分。

要点

  • 影像组学列线图全队列AUC为0.909(0.864-0.954),高于ACR TI-RADS评分(P<0.001)。
  • 列线图不必要细针穿刺率显著低于ACR TI-RADS评分(P=0.007)。
  • 列线图诊断性能、不必要穿刺率及净临床获益与TI-RADS+SE+CEUS评分相当(P分别为0.753、0.457)。

核心结论

  • 本研究构建的影像组学列线图可作为客观、准确、经济、无创的方法用于甲状腺结节的定性诊断。

研究设计与样本

  • 回顾性研究,纳入217个甲状腺结节,分为训练集152个和验证集65个;基于B型超声和应变弹性成像图像提取影像组学评分;参考标准为ACR TI-RADS评分及TI-RADS+SE+CEUS高级临床评分。

诊断标准与关键数值

  • B-US影像组学评分训练集AUC为0.753(0.668-0.825),验证集AUC为0.732(0.579-0.867);SE评分训练集AUC为0.761(0.674-0.838),验证集AUC为0.753(0.609-0.892);B-US+SE评分训练集AUC为0.795(0.715-0.871),验证集AUC为0.752(0.592-0.899);列线图全队列AUC为0.909(0.864-0.954)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To develop a radiomics model with enhanced diagnostic performance, reduced unnecessary fine needle aspiration biopsy (FNA) rate, and improved clinical net benefit for thyroid nodules.

METHODS: We conducted a retrospective study of 217 thyroid nodules. Lesions were divided into training (n = 152) and verification (n = 65) cohorts. Three radiomics scores were derived from B-mode ultrasound (B-US) and strain elastography (SE) images, alone and in combination. A radiomics nomogram was constructed by combining high-frequency ultrasonic features and the best-performing radiomics score. The area under the receiver operating characteristic curve (AUC), unnecessary FNA rate, and decision curve analysis (DCA) results for the nomogram were compared to those obtained with the American College of Radiology Thyroid Imaging, Reporting and Data System (ACR TI-RADS) score and the combined TI-RADS+SE+ contrast-enhanced ultrasound (CEUS) advanced clinical score.

RESULTS: The three radiomics scores (B-US, SE, B-US+SE) achieved training AUCs of 0.753 (0.668-0.825), 0.761 (0.674-0.838), and 0.795 (0.715-0.871), and validation AUCs of 0.732 (0.579-0.867), 0.753 (0.609-0.892), and 0.752 (0.592-0.899) respectively. The AUC of the nomogram for the entire patient cohort was 0.909 (0.864-0.954), which was higher than that of the ACR TI-RADS score (P < 0.001) and equivalent to the TI-RADS+SE+CEUS score (P = 0.753). Similarly, the unnecessary FNA rate of the radiomics nomogram was significantly lower than that of the ACR TI-RADS score (P = 0.007) and equivalent to the TI-RADS+SE+CEUS score (P = 0.457). DCA also showed that the radiomics nomogram brought more net clinical benefit than the ACR TI-RADS score but was similar to that of the TI-RADS+SE+CEUS score.

CONCLUSION: The radiomics nomogram developed in this study can be used as an objective, accurate, cost-effective, and noninvasive method for the characterization of thyroid nodules.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang YJ, Xue T, Liu C, et al. Radiomics Combined with ACR TI-RADS for Thyroid Nodules: Diagnostic Performance, Unnecessary Biopsy Rate, and Nomogram Construction. Acad Radiol. 2024. PMID: 39366806. doi:10.1016/j.acra.2024.07.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。